Literature DB >> 17095613

Activation of RAGE induces elevated O2- generation by mononuclear phagocytes in diabetes.

Yong Ding1, Alpdogan Kantarci, Hatice Hasturk, Philip C Trackman, Alan Malabanan, Thomas E Van Dyke.   

Abstract

Oxidative stress has been found to play a role in the pathogenesis of diabetic complications. The aim of this study was to define the oxidative burst of diabetic monocytes to characterize the phenotype associated with poor diabetic control. Superoxide (O(2)(-)) is the first molecule generated during the respiratory burst of phagocytes by NADPH oxidase, and its generation by monocytes from 26 controls and 34 diabetic subjects was evaluated in this study. Under resting states or stimulation by PMA or opsonized zymosan, diabetic monocytes produce significantly more O(2)(-) than nondiabetic cells. The increased O(2)(-) generation was found to be correlated with glycemic control (glycated hemoglobin) of patients. To clarify the effects of hyperglycemia on O(2)(-) generation, normal human monocytes were treated with receptor for advanced glycation endproducts (RAGE) ligands (AGE protein and S100B) or high glucose media before stimulation. RAGE ligands and high glucose concentration increased O(2)(-) generation from human mononuclear phagocytes. RAGE ligands, specifically and potently, increased O(2)(-) generation from mononuclear phagocytes, and high-glucose effects were associated with correspondingly increased osmotic pressure. Differentiated THP-1 cells, from a human monocytic cell line, were used as a model of human monocytes to study the effects of S100B, the RAGE ligand. It was confirmed that RAGE is involved in the priming of O(2)(-) generation by S100B. This study demonstrates that RAGE ligands can contribute significantly to the hyper-responsive phenotype of diabetic monocytes, which might be reversible by blocking the RAGE or controlling the presence of RAGE ligands by controlling hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17095613      PMCID: PMC2533418          DOI: 10.1189/jlb.0406262

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  37 in total

Review 1.  The AGE-receptor in the pathogenesis of diabetic complications.

Authors:  H Vlassara
Journal:  Diabetes Metab Res Rev       Date:  2001 Nov-Dec       Impact factor: 4.876

2.  Influence of non-enzymatically glycated collagen on monocyte-macrophage differentiation.

Authors:  S S Jacob; P Shastry; P R Sudhakaran
Journal:  Atherosclerosis       Date:  2001-12       Impact factor: 5.162

3.  Diabetes guidelines: a summary and comparison of the recommendations of the American Diabetes Association, Veterans Health Administration, and American Association of Clinical Endocrinologists.

Authors:  M J Clark; J J Sterrett; D S Carson
Journal:  Clin Ther       Date:  2000-08       Impact factor: 3.393

Review 4.  Advanced glycation end products and the progressive course of renal disease.

Authors:  A Heidland; K Sebekova; R Schinzel
Journal:  Am J Kidney Dis       Date:  2001-10       Impact factor: 8.860

5.  Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice.

Authors:  M T Goova; J Li; T Kislinger; W Qu; Y Lu; L G Bucciarelli; S Nowygrod; B M Wolf; X Caliste; S F Yan; D M Stern; A M Schmidt
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

6.  Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: the effect of alpha-tocopherol supplementation.

Authors:  S Devaraj; I Jialal
Journal:  Circulation       Date:  2000-07-11       Impact factor: 29.690

7.  The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control.

Authors:  Francesco Cipollone; Annalisa Iezzi; Maria Fazia; Mirco Zucchelli; Barbara Pini; Chiara Cuccurullo; Domenico De Cesare; Giovanni De Blasis; Raffaella Muraro; Roberto Bei; Francesco Chiarelli; Ann Marie Schmidt; Franco Cuccurullo; Andrea Mezzetti
Journal:  Circulation       Date:  2003-08-11       Impact factor: 29.690

8.  17beta-estradiol inhibits NADPH oxidase activity through the regulation of p47phox mRNA and protein expression in THP-1 cells.

Authors:  Daigo Sumi; Toshio Hayashi; Hisako Matsui-Hirai; Aaron T Jacobs; Louis J Ignarro; Akihisa Iguchi
Journal:  Biochim Biophys Acta       Date:  2003-05-12

9.  Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are able to reduce superoxide anion production by NADPH oxidase in THP-1-derived monocytes.

Authors:  Sandrine Delbosc; Marion Morena; Farida Djouad; Christian Ledoucen; Bernard Descomps; Jean-Paul Cristol
Journal:  J Cardiovasc Pharmacol       Date:  2002-10       Impact factor: 3.105

Review 10.  Cellular response to oxidative stress: signaling for suicide and survival.

Authors:  Jennifer L Martindale; Nikki J Holbrook
Journal:  J Cell Physiol       Date:  2002-07       Impact factor: 6.384

View more
  29 in total

1.  Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis.

Authors:  Sarah L Ullevig; Qingwei Zhao; Debora Zamora; Reto Asmis
Journal:  Atherosclerosis       Date:  2011-06-17       Impact factor: 5.162

2.  Controlling the mechanical properties of three-dimensional matrices via non-enzymatic collagen glycation.

Authors:  Brooke N Mason; Cynthia A Reinhart-King
Journal:  Organogenesis       Date:  2013-04-01       Impact factor: 2.500

Review 3.  Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer.

Authors:  Geetha Srikrishna; Hudson H Freeze
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

4.  Burkholderia pseudomallei triggers altered inflammatory profiles in a whole-blood model of type 2 diabetes-melioidosis comorbidity.

Authors:  Jodie Morris; Natasha Williams; Catherine Rush; Brenda Govan; Kunwarjit Sangla; Robert Norton; Natkunam Ketheesan
Journal:  Infect Immun       Date:  2012-04-02       Impact factor: 3.441

5.  Erythropoietin attenuates advanced glycation endproducts-induced toxicity of Schwann cells in vitro.

Authors:  Ting Yu; Lei Li; Tianhua Chen; Zhen Liu; Huaxiang Liu; Zhenzhong Li
Journal:  Neurochem Res       Date:  2015-01-14       Impact factor: 3.996

6.  Phosphorylation of pleckstrin increases proinflammatory cytokine secretion by mononuclear phagocytes in diabetes mellitus.

Authors:  Yong Ding; Alpdogan Kantarci; John A Badwey; Hatice Hasturk; Alan Malabanan; Thomas E Van Dyke
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

7.  Tuning three-dimensional collagen matrix stiffness independently of collagen concentration modulates endothelial cell behavior.

Authors:  Brooke N Mason; Alina Starchenko; Rebecca M Williams; Lawrence J Bonassar; Cynthia A Reinhart-King
Journal:  Acta Biomater       Date:  2012-08-16       Impact factor: 8.947

8.  Diabetes-induced oxidative stress is mediated by Ca2+-independent phospholipase A2 in neutrophils.

Authors:  Srinivas Ayilavarapu; Alpdogan Kantarci; Gabrielle Fredman; Oya Turkoglu; Kazuhiro Omori; Hongsheng Liu; Tomoyuki Iwata; Motohiko Yagi; Hatice Hasturk; Thomas E Van Dyke
Journal:  J Immunol       Date:  2010-01-06       Impact factor: 5.422

Review 9.  22016 ATVB Plenary Lecture: Receptor for Advanced Glycation Endproducts and Implications for the Pathogenesis and Treatment of Cardiometabolic Disorders: Spotlight on the Macrophage.

Authors:  Ann Marie Schmidt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-02-09       Impact factor: 8.311

Review 10.  Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2012-08-12       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.